Keratin 14 (KRT14) (C-Term) antibody

Details for Product No. ABIN118965
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms K14, NFJ, CK14, EBS3, EBS4, Krt1-14, AI626930, Krt-1.14, Ka14, Krt14, KRT14, ouro2
(39), (4), (2), (1), (1), (1), (1), (1), (1)
(127), (24), (20), (7), (4), (3), (2)
(68), (57), (4)
Clonality (Clone)
Monoclonal ()
(3), (3)
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC), Immunofluorescence (IF), Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(79), (73), (39), (29), (24), (17), (17), (15), (2), (2), (2)
Pubmed 9 references available
Catalog no. ABIN118965
Quantity 0.2 mg
467.50 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 6 to 8 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Last 15 C-terminal residues of Human Cytokeratin 14 conjugated to Thyroglobulin.
Clone LL002
Isotype IgG3
Specificity This antibody recognises Cytokeratin 14, a type I intermediate filament, expressed by stratifying epithelial cells and can be used to distinguish these cell types from simple epithelial cells, which do not express Cytokeratin 14.
Purification Ion Exchange Chromatography
Alternative Name Cytokeratin 14
Background Cytokeratin is a type I intermediate filament, expressed by stratifying epithelial cells and can be used to distinguish these cell types from simple epithelial cells, which do not express cytokeratin 14. Keratin 14 is a member of the keratin family, the most diverse group of intermediate filaments. It is usually found as a heterotetramer with two molecules of keratin 5, a type II keratin. Together they form the cytoskeleton of epithelial cells. Mutations in the genes for these keratins are associated with epidermolysis bullosa simplex. Keratin 14 has been studied as a prognostic marker in breast cancer.
Alternate names: CK14, Cytokeratin-14, K14, KRT14, Keratin 14, Keratin Type I Cytoskeletal 14
Gene ID 3861
NCBI Accession NP_000517.2
UniProt P02533
Research Area Signaling, Cytoskeleton, Cytokeratins, Extracellular Matrix, Cancer
Application Notes Flow Cytometry: Use 10 ul of 1/100 diluted antibody to label 10e6 cells in 100 ul (Membrane permeabilisation is required). Western Blot. Immunohistochemistry on Frozen Sections. Immunohistochemistry on Paraffin Sections (1/200): This product requires antigen retrieval using heat treatment prior to staining of paraffin sections, Sodium citrate buffer is recommended for this purpose, Enzyme digestion is not recommended. Recommended Positive Control: Skin. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Concentration 1.0 mg/mL
Buffer PBS 0.09% Sodium Azide
Preservative Sodium azide
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Expiry Date 12 months
Background publications Purkis, Steel, Mackenzie et al.: "Antibody markers of basal cells in complex epithelia." in: Journal of cell science, Vol. 97 ( Pt 1), pp. 39-50, 1991 (PubMed).

Lane, Alexander: "Use of keratin antibodies in tumor diagnosis." in: Seminars in cancer biology, Vol. 1, Issue 3, pp. 165-79, 1991 (PubMed).

Wetzels, Holland, van Haelst et al.: "Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast." in: The American journal of pathology, Vol. 134, Issue 3, pp. 571-9, 1989 (PubMed).

Moll, Franke, Schiller et al.: "The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells." in: Cell, Vol. 31, Issue 1, pp. 11-24, 1983 (PubMed).

Varley, Stahlschmidt, Smith et al.: "Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells." in: The American journal of pathology, Vol. 164, Issue 5, pp. 1789-98, 2004 (PubMed).

Matos, Faustino, Lopes et al.: "Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining." in: The Veterinary record, Vol. 158, Issue 18, pp. 626-30, 2006 (PubMed).

Takahashi, Yoshida, Komine et al.: "Newly established cell lines from mouse oral epithelium regenerate teeth when combined with dental mesenchyme." in: In vitro cellular & developmental biology. Animal, Vol. 46, Issue 5, pp. 457-68, 2010 (PubMed).

Turner, Subramanian, Thomas et al.: "Transplantation of autologous differentiated urothelium in an experimental model of composite cystoplasty." in: European urology, Vol. 59, Issue 3, pp. 447-54, 2011 (PubMed).

Abdeen, Salah, Maly et al.: "Wwox inactivation enhances mammary tumorigenesis." in: Oncogene, Vol. 30, Issue 36, pp. 3900-6, 2011 (PubMed).

Hosts (68), (57), (4)
Reactivities (127), (24), (20), (7), (4), (3), (2)
Applications (79), (73), (39), (29), (24), (17), (17), (15), (2), (2), (2)
Conjugates (3), (3)
Epitopes (39), (4), (2), (1), (1), (1), (1), (1), (1)
back to top